Legend Stock Analysis

LEGN Stock  USD 46.97  0.19  0.40%   
The small decline in market price for the last few months may encourage insiders to take a closer look at the firm as it is trading at a share price of 46.97 on 275,323 in trading volume. The company executives did not add much value to Legend BiotechCorp investors in February. However, diversifying your holdings with Legend BiotechCorp or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.83. The current volatility is consistent with the ongoing market swings in February 2023 as well as with Legend BiotechCorp unsystematic, company-specific events.
Check out Correlation Analysis. To learn how to invest in Legend Stock please use our How to Invest in Legend BiotechCorp guide.
The main objective of Legend BiotechCorp stock analysis is to determine its intrinsic value, which is an estimate of what Legend BiotechCorp is worth, separate from its market price. There are two main types of Legend BiotechCorp's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Legend BiotechCorp's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Legend BiotechCorp's stock to identify patterns and trends that may indicate its future price movements.
The Legend BiotechCorp stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Legend BiotechCorp is usually not traded on Thanksgiving Day, Christmas Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Legend Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Legend BiotechCorp's ongoing operational relationships across important fundamental and technical indicators.

Legend Stock Analysis Notes

About 39.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.96. Legend BiotechCorp had not issued any dividends in recent years. Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1071 people. To find out more about Legend BiotechCorp contact Ying Huang at 732 317 5050 or learn more at https://www.legendbiotech.com.

Legend BiotechCorp Quarterly Cost of Revenue

16.94 Million

Legend BiotechCorp Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Legend BiotechCorp's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Legend BiotechCorp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Legend BiotechCorp generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 89.79 M. Net Loss for the year was (386.21 M) with profit before overhead, payroll, taxes, and interest of 91.56 M.
Legend BiotechCorp currently holds about 791.26 M in cash with (198.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Legend BiotechCorp has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: Should You Retain Your Holdings in Legend Biotech Corporation

Legend BiotechCorp Upcoming and Recent Events

Earnings reports are used by Legend BiotechCorp to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Legend BiotechCorp previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
31st of March 2023
Upcoming Quarterly Report
7th of June 2023
Next Financial Report
31st of December 2022
Next Fiscal Quarter End
31st of March 2023
Next Fiscal Year End
30th of September 2022
Last Quarter Report
31st of December 2021
Last Financial Announcement

Legend Largest EPS Surprises

Earnings surprises can significantly impact Legend BiotechCorp's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates
View All Earnings Estimates

Legend BiotechCorp SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Legend BiotechCorp prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Legend BiotechCorp investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Legend BiotechCorp specific information freely available to individual and institutional investors to make a timely investment decision.
17th of February 2023
Other Events
14th of February 2023
Unclassified Corporate Event
9th of February 2023
Unclassified Corporate Event
27th of January 2023
Other Events
24th of January 2023
Other Events
9th of January 2023
Other Events
3rd of January 2023
Other Events
8th of December 2022
Other Events

Legend Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Legend BiotechCorp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Legend BiotechCorp backward and forwards among themselves. Legend BiotechCorp's institutional investor refers to the entity that pools money to purchase Legend BiotechCorp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last TransactionTypeSharesValue
Fmr Llc2022-12-31Common Shares15.1 M755.9 M
Hhlr Advisors Ltd2022-12-31Common Shares5.1 M256.4 M
Blackrock Inc2022-12-31Common Shares3.9 M193.6 M
Ra Capital Management Lp2022-12-31Common Shares2.4 M121.6 M
Capital World Investors2022-12-31Common Shares2.4 M119.3 M
Federated Hermes Inc2022-12-31Common Shares2.3 M116.8 M
Capital International Investors2022-12-31Common Shares2.2 M108.3 M
Janus Henderson Group Plc2022-12-31Common Shares1.8 M92.2 M
Wellington Management Group Llp2022-12-31Common Shares1.8 M90.5 M
Johnson Johnson2022-12-31Common Shares1.6 M81.3 M
Alliancebernstein Lp2022-12-31Common Shares1.3 M64.5 M
Note, although Legend BiotechCorp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Legend Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.71 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Legend BiotechCorp's market, we take the total number of its shares issued and multiply it by Legend BiotechCorp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Legend Profitablity

Legend BiotechCorp's profitability indicators refer to fundamental financial ratios that showcase Legend BiotechCorp's ability to generate income relative to its revenue or operating costs. If, let's say, Legend BiotechCorp is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Legend BiotechCorp's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Legend BiotechCorp's profitability requires more research than a typical breakdown of Legend BiotechCorp's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2023
Return on Average Assets(0.42) (0.46) 
Return on Average Equity(1.17) (1.26) 
Return on Invested Capital(11.51) (12.42) 
Return on Sales(5.31) (5.45) 

Management Efficiency

The entity has return on total asset (ROA) of (0.2565) % which means that it has lost $0.2565 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.9733) %, meaning that it created substantial loss on money invested by shareholders. Legend BiotechCorp management efficiency ratios could be used to measure how well legend biotechcorp manages its routine affairs as well as how well it operates its assets and liabilities. As of 27th of March 2023, Return on Average Assets is likely to drop to -0.46. In addition to that, Return on Average Equity is likely to drop to -1.26. Legend BiotechCorp Goodwill and Intangible Assets are very stable at the moment as compared to the past year. Legend BiotechCorp reported last year Goodwill and Intangible Assets of 5.39 Million. As of 27th of March 2023, Asset Turnover is likely to grow to 0.09, while Total Assets are likely to drop about 1 B.
Last ReportedProjected for 2023
Book Value per Share 3.85  4.15 
Enterprise Value over EBIT(13.50) (14.56) 
Enterprise Value over EBITDA(14.43) (15.57) 
Price to Book Value 16.53  16.63 
Tangible Assets Book Value per Share 9.09  8.04 
Enterprise Value7.2 B6.5 B
Tangible Asset Value1.3 BB
The analysis of Legend BiotechCorp's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Legend BiotechCorp's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Legend Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Non Current Liabilities Total
366.9 M
Short Long Term Debt Total
123 M
Interest Expense
900 K
Total Operating Expenses
462.8 M

Technical Drivers

As of the 27th of March, Legend BiotechCorp secures the risk adjusted performance of (0.015622), and Mean Deviation of 2.16. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Legend BiotechCorp, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Legend BiotechCorp, which can be compared to its peers in the industry. Please verify Legend BiotechCorp variance, as well as the relationship between the maximum drawdown and semi variance to decide if Legend BiotechCorp is priced some-what accurately, providing market reflects its recent price of 46.97 per share. Given that Legend BiotechCorp has jensen alpha of (0.042439), we recommend you to check Legend BiotechCorp's last-minute market performance to make sure the company can sustain itself at a future point.

Legend BiotechCorp Price Movement Analysis

null. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Legend BiotechCorp price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Legend BiotechCorp Predictive Daily Indicators

Legend BiotechCorp intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Legend BiotechCorp stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Legend BiotechCorp Forecast Models

Legend BiotechCorp time-series forecasting models is one of many Legend BiotechCorp's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Legend BiotechCorp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Legend Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Legend BiotechCorp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Legend shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Legend BiotechCorp. By using and applying Legend Stock analysis, traders can create a robust methodology for identifying Legend entry and exit points for their positions.
Last ReportedProjected for 2023
EBITDA Margin(5.13) (5.26) 
Gross Margin 0.90  0.89 
Profit Margin(5.28) (5.42) 

Current Legend Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Legend analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Legend analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Legend BiotechCorp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Legend analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Legend stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Legend BiotechCorp, talking to its executives and customers, or listening to Legend conference calls.
Legend Analyst Advice Details

Legend Stock Analysis Indicators

Legend BiotechCorp stock analysis indicators help investors evaluate how Legend BiotechCorp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Legend BiotechCorp shares will generate the highest return on investment. By understating and applying Legend BiotechCorp stock analysis, traders can identify Legend BiotechCorp position entry and exit signals to maximize returns.
Begin Period Cash Flow455.7 M
Common Stock Shares Outstanding140.9 M
Total Stockholder Equity471.2 M
Total Cashflows From Investing Activities-195 M
Tax Provision1000.00
Property Plant And Equipment Net155.1 M
Retained Earnings-817 M
Cash And Short Term Investments882.4 M
Cash688.9 M
Accounts PayableM
Net Debt-566 M
50 Day M A48.9958
Total Current Liabilities280.3 M
Other Operating Expenses462.8 M
Non Current Assets Total169.6 M
Non Currrent Assets Other9.8 M
Stock Based Compensation20.2 M
Check out Correlation Analysis. To learn how to invest in Legend Stock please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Transaction History
View history of all your transactions and understand their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine Legend BiotechCorp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.